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Abstract  32 
Both blood- and milk-based biomarkers have been analysed for decades in research 33 
settings, although often only in one herd, and without focus on the variation in the 34 
biomarkers that are specifically related to herd or diet.  Biomarkers can be used to 35 
detect physiological imbalance and disease risk, and may have a role in precision 36 
livestock farming (PLF). For use in PLF it is important to quantify normal variation in 37 
specific biomarkers and the source of this variation. The objective of this study was to 38 
estimate the between and within-herd variation in a number of blood metabolites (β-39 
hydroxybutyrate (BHB), non-esterified fatty acids, glucose and serum IGF-1), milk 40 
metabolites (free glucose, glucose-6-phosphate, urea, isocitrate, BHB and uric acid), 41 
milk enzymes (lactate dehydrogenase and N-acetyl-β-D-glucosaminidase (NAGase)) 42 
and composite indicators for metabolic imbalances (Physiological Imbalance-index 43 
(PI-index) and energy balance (EBAL)), to help facilitate their adoption within PLF. 44 
Blood and milk were sampled from 234 Holstein dairy cows from six experimental 45 
herds, each in a different European country, and  offered a total of 10 different diets. 46 
Blood was sampled on two occasions at approximately 14 days-in-milk (DIM) and 35 47 
DIM.  Milk samples were collected twice weekly (in total 2750 samples) from DIM 1 to 48 
50. Multilevel random regression models were used to estimate the variance 49 
components and to calculate the Intra-Class Correlations (ICC). The ICCs for the 50 
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milk metabolites, when adjusted for parity and DIM at sampling, demonstrated that 51 
between 12% (glucose-6-phosphate) to 46% (urea) of the variation in the 52 
metabolites’ levels could be associated with the herd-diet combination. ICC related to 53 
the herd-diet combination were generally higher for blood metabolites; from 17% 54 
(cholesterol) to approximately 46% (BHB and urea). The high ICC for for urea 55 
suggest that this biomarker can be used for monitoring on herd level. The low 56 
variance within cow for NAGase indicate that few samples would be needed to 57 
describe the status and potentially a general reference value could be used. The low 58 
ICC for most of the biomarkers and larger within cow variation emphasizes that 59 
multiple samples would be needed most likely on the individual cows for making the 60 
biomarkers useful for monitoring. The majority of biomarkers were influenced by 61 
parity and DIM which indicate that these should be accounted for if the biomarker 62 
should be used for monitoring. 63 
 64 
 65 
Keywords: dairy, biomarker, physiological imbalance, variance, monitoring 66 
 67 
Implications  68 
We quantified normal variation in blood- and milk-based biomarkers of health and 69 
performance among cows housed in very different feeding and housing conditions. 70 
Some biomarkers like urea were strongly affected by herd factors, which make them 71 
very useful for herd-level monitoring. Some biomarkers like N-acetyl-β-D-72 
glucosaminidase (NAGase) were very uniform from day to day at cow level, which 73 
make it possible to monitor health and performance with few samples and sometimes 74 
to use general reference values. Most biomarkers were substantively affected by 75 
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factors like parity and stage of lactation, which demonstrates that these factors must 76 
be accounted for in monitoring programs. 77 
 78 
Introduction 79 
Modern dairy farming faces many challenges, including the need to optimise 80 
production efficiency, while at the same time maintaining the physiological balance, 81 
health and fertility of the cows. High yielding dairy cows in early lactation frequently 82 
suffer from their inability to consume sufficient feed to support the amount of energy 83 
required for maintenance and milk production, leading to negative energy balance 84 
(EBAL), which is reflected in the mobilisation of body reserves. If this mobilisation is 85 
too extensive, this may create physiological imbalances, which in turn make the 86 
animal more susceptible to both metabolic and infectious diseases (Ingvartsen, 87 
2006). To date, most indicators of physiological imbalance have been based on 88 
measurements of blood metabolites (e.g. β-hydroxybutyrate (BHB), non-esterified 89 
fatty acids (NEFAs), glucose and urea), and hormones such as serum IGF-1 90 
(Chagas et al., 2007; Wathes et al., 2007; Ingvartsen and Moyes, 2013). Milk 91 
enzymes such as N-acetyl-β-D-glucosaminidase (NAGase) and lactate 92 
dehydrogenase (LDH) also show potential as biomarkers to describe udder health. 93 
Currently tests for BHB in milk and blood and blood glucose (Mair et al., 2016) and 94 
LDH can be conducted cow-side.  95 
New spectrophotometric techniques such as Fourier transform mid-IR (FT-96 
MIR) spectra of milk show promising perspectives to provide more timely information 97 
for improved herd management in relation to metabolic health. FT-MIR can reliably 98 
predict the concentrations of BHB, acetone and citrate (Grelet et al., 2016a). It is 99 
highly likely that other metabolites can also be predicted from FT-MIR, and this would 100 
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reduce the costs (and possibly time) associated with more traditional biochemical 101 
methods and provide the possibility to have more detailed time series of 102 
observations. Such developments lead to the potential for incorporating the 103 
monitoring of metabolic health into the area of precision livestock farming (PLF). 104 
Berckmans (2017) defined PLF as managing individual animals by continuous real-105 
time monitoring of health, welfare and production. In non-biological production 106 
systems, process control charts are often used to monitor the production system, 107 
however they have also been applied in animal production (Mertens et al., 2011). 108 
One approach of what should be monitored in process control is that it is not the 109 
outcome of the production process that is monitored but a suitable indicator of the 110 
production process that mirrors the current state of the production system (Mertens 111 
et al., 2011). The goal is to have a production process where the amount or quality of 112 
the process outcome will be predictable using the indicator. Despite a production 113 
process being predictable, it does not necessarily mean that it is also acceptable.  114 
Using this terminology with respect to the present paper, process outcome refers to 115 
the occurrence of metabolic diseases and indicators refer to the observations of the 116 
individual cows’ metabolic status measured by the biomarkers. The production 117 
process is then predictable if the biomarkers can predict the occurrence of metabolic 118 
diseases, but if not predictable, assignable cause of process variation should be 119 
eliminated. Process control charts were a natural predecessor of PLF although to 120 
develop both, detailed information about the normal variation in the control input is 121 
needed.  Milk and blood biomarkers have been analysed for decades in research 122 
settings (Andersson, 1984; Jensen et al., 1993) and in some commercial herds 123 
(Stengärde et al., 2010). Very often the observations come from one research herd, 124 
making the estimation of herd variance impossible. When multiple herds are 125 
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included, herd effects are often treated as uninteresting covariates that are all too 126 
often removed to elucidate the research question (e.g. Ospina et al., 2010; Seifi et 127 
al., 2011). If substantial between- and within-herd variation exists in blood and milk 128 
biomarkers, this may result in poor predictions of the process outcome. The four 129 
different levels of variation (random, within-cow/temporal, cow-level and herd-level) 130 
are described as follows. 1) Random variation, due to measurement error induced by 131 
sampling or analytical error. 2) The temporal within cow variation in the biomarker: 132 
this is due to diurnal variation (Nielsen et al., 2003) and differences in sampling time 133 
relative to feeding.  Both random and within cow variation should be minor compared 134 
to the difference in means between the healthy and imbalanced population, 135 
otherwise there will be substantial misclassification of the truly healthy versus truly 136 
imbalanced cows. This could be accounted for by more observations from each cow 137 
or by adjusting for diurnal patterns. 3) Variation in the biomarker due to differences 138 
between cows: this source of variation arises from cows responding differently to the 139 
same metabolic challenge, even if they remain healthy. Genetic differences between 140 
individual cows that result in some metabolic pathways functioning more efficiently 141 
than others could result in systematic differences in baseline levels of the 142 
biomarkers. Such genetic differences in EBAL have been found (Berry et al., 2007). 143 
Also, the cow’s physiological constitution could provide systematic differences in the 144 
biomarkers: for example two cows with the same challenge in terms of EBAL would 145 
most likely respond very differently in blood/milk BHB depending on their body 146 
condition. This is related to construct validity (O'Leary-Kelly and Vokurka, 1998) 147 
where it should be carefully evaluated if the observed biomarker actually measure 148 
what it is intended to –here the metabolic challenge the cow is exposed to. The 149 
importance of cow-to-cow variation within healthy or imbalanced cows depends on 150 
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the size of the variation, compared to differences between balanced and imbalanced 151 
cows. If cow-to-cow variations are large within healthy cows, then biomarker 152 
observations that are normal for one cow could be imbalanced for another, thus 153 
requiring multiple observations on individual cows for PLF tools to function. Additional 154 
observations of the individual cow will not improve this issue, because repeated 155 
observations within an individual cow will be correlated. 4) Variation in individual cow 156 
biomarkers that can be attributed to all cows in the herd: for example, feeding 157 
strategy will clearly affect the metabolic status of cows in any herd, and dependent 158 
on the diet, a small or large number of cows may be imbalanced. Herd variation, 159 
however, means that the same diet may result in specific patterns or levels of 160 
biomarkers in different herds, dependent on other management factors such as 161 
milking frequency, feed management, stocking density etc. Such management 162 
factors could, for example, affect biomarkers by influencing the glucocorticoid levels 163 
(Huzzey et al., 2012) that influence energy metabolism. Another explanation for herd 164 
variation could be the presence of dominant genotypes within herds, so it is actually 165 
an accumulated cow-effect. The importance of the herd variation in biomarkers is 166 
again dependent on differences in the biomarkers between the imbalanced and 167 
healthy population. The implication of this sort of variation is that multiple 168 
observations within each herd is needed to adjust the PLF-tool to the herd specific 169 
threshold.        170 
The objective of this study was to estimate the between- and within-herd 171 
variation in key blood metabolites/hormones (BHB, NEFA, glucose, urea, 172 
fructosamine, cholesterol and IGF-1), milk metabolites/enzymes (BHB, glucose, urea, 173 
isocitrate, glucose-6-phosphate, uric acid, NAGase and LDH) and composite 174 
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indicators for metabolic imbalances (EBAL and PI-index), so as to assist the 175 
implementation of these into PLF.  176 
 177 
Material and methods 178 
Animals, data storage and transportation of samples 179 
A comprehensive set of samples and data were collected between calving and 180 
50 days post calving (1-50 days in milk (DIM)) from 241 Holstein cows in six research 181 
herds: 35 from DK (Aarhus University, Denmark); 39 from IE (UCD Lyons Research 182 
Farm, University College Dublin, Ireland); 62 from UK (Agri-Food and Biosciences 183 
Institute, Northern Ireland, UK); 31 from BE (Walloon Agricultural Research Centre, 184 
Belgium); 29 from DE (Leibniz Institute for Farm Animal Biology, Germany), and 45 185 
from IT (Consiglio per la Ricerca in Agricoltura, Italy). Seven cows were culled before 186 
50 DIM (one UK, three DE, and three IE) and were subsequently excluded, thus data 187 
from 234 cows were available for analyses. Of these 234 cows, 55 were in parity 1, 188 
66 were in parity 2 and 113 were in parity ≥3 (3+), giving an overall median lactation 189 
number of 2 (max lactation number 7). All data were stored in a central repository at 190 
Dairy Data Warehouse, The Netherlands. Data were checked for errors, validity and 191 
agreement between original data and data from the repository. Blood plasma, serum 192 
and milk samples were transported frozen between the place of collection and the 193 
appropriate laboratory by commercial transport companies. Samples were shipped in 194 
insulated containers in the presence of dry ice. The consignments were in all 195 
instances checked for residual dry ice at reception. 196 
 197 
Diets and feed intake 198 
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Cows in two of the herds (UK and DK) were offered three contrasting diets, 199 
some of which were designed to challenge the cows metabolically (the ‘High sugar’ 200 
diet should be ketogenic and the ‘High starch’ should induce acidosis in DK), while 201 
cows in the remaining four herds were offered diets which reflected local 202 
management practices (Table 1). Automated electronic feed intake recording 203 
systems were used to record daily intakes of individual cows from DK/IE  (Insentec, 204 
Markneesse, Netherlands), and UK (Calan gates linked to an automatic cow 205 
identification system  (American Calan, Northwood, NH), which allowed cows to gain 206 
access to feed boxes mounted on weighing scales (Griffith Elder, Bury St. Edmunds, 207 
UK)).  In DE, the total mixed ration was placed in troughs on scales, connected to a 208 
computer. Feed intakes were not recorded in BE or IT. 209 
 210 
Milk yield and composition 211 
All cows were milked twice daily and yields (volumes) were recorded from 212 
approximately three DIM. Milk samples, containing Bronopol 0.02% as a 213 
preservative, were collected from consecutive morning and evening milkings twice 214 
weekly from seven DIM onwards, stored at 4°C and subsequently analysed by FT-215 
MIR for composition of protein, fat and lactose. The morning and evening 216 
compositions were weighted for milk yields to provide a daily weighted average 217 
composition. 218 
 219 
Live body weight recording and health records 220 
Live body weights of cows were recorded on at least two occasions over the 221 
seven-week period from all herds except IT. The frequency of weighing differed 222 
markedly between herds: DK and UK at every milking (i.e. twice per day), IE and DE 223 
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on average two and three times per week, and BE twice during the study period (at 224 
approximately 14 and 35 DIM). Details of health problems and their treatments for 225 
individual cows were obtained from herd health records. The detection of health 226 
problems and subsequent treatment followed the normal management practice in the 227 
herds. No attempts were made to assess the agreement between diagnostic 228 
procedures in different countries. 229 
 230 
Blood sampling and analyses of metabolites and IGF-1 231 
At approximately 14 DIM (mean=14.1, SD=2.0, range: 11 to 20) and 35 DIM 232 
(mean=34.8, SD=1.9, range: 31 to 38), blood samples were collected by jugular 233 
venepuncture to obtain plasma (in Na heparin tubes) and serum (plain tubes): 234 
plasma and serum were separated by centrifugation, and stored at -20°C for 235 
subsequent analysis. Urea and cholesterol were determined in plasma according to 236 
standard procedures using an auto-analyser, ADVIA 1800 ® Chemistry System 237 
(Siemens Medical Solutions, Tarrytown, NY 10591, USA). Glucose, NEFA, BHB and 238 
fructosamine were determined according to Bjerre-Harpoth et al. (2016). Intra- and 239 
inter-assay CV were in all cases below three and four percent, respectively, for both 240 
low and high control samples. Laboratory analyses of all blood metabolites were 241 
carried out at the Department of Animal Science, Aarhus University, Denmark. 242 
Concentrations of IGF-1 were determined in serum by radioimmunoassay at 243 
University College Dublin, Ireland, following acid–ethanol extraction using the method 244 
as described by Beltman et al. (2010). Intra-assay CVs were 12.4, 7.5 and 9.9% for 245 
low, medium and high control samples, respectively. The corresponding inter-assay 246 
CVs were 7.8, 3.9 and 9.4%. The sensitivity of the assay, defined as the lowest 247 




Milk sampling and analysis for metabolites and enzymes 250 
Additional milk samples were collected twice weekly during morning milking, 251 
starting at around seven DIM. On each occasion, two 8 ml samples were obtained 252 
and stored at -18°C in tubes with stoppers. Fluorometric end point analyses were 253 
used to determine milk glucose and glucose-6-phosphate (Larsen, 2015), uric acid 254 
(Larsen and Moyes, 2010), isocitrate (Larsen, 2014) and BHB (Larsen and Nielsen, 255 
2005). Urea was determined by spectrophotometry (Nielsen et al., 2005). The 256 
indigenous enzymes LDH (EC. 1.1.1.27) and NAGase (EC 3.2.1.30) were analysed 257 
by fluorometric assays according to Larsen (2005) and Larsen et al. (2010). Intra- 258 
and inter-assay CV were in all cases below five and eight percent, respectively, for 259 
both low and high control samples. The analysis of milk metabolites and enzymes 260 
was carried out at the Department of Animal Science, Aarhus University, Denmark. 261 
 262 
Derived measures 263 
Feed samples were collected weekly from UK, DK and IE were analysed for 264 
Net Energy for Lactation (NEL) in a single run at Cumberland Valley Agricultural 265 
Services, Maryland. EBAL (in MJ/day), derived from NEL, was determined according 266 
to the National Research Council (NRC, 2001): EBAL = NEL feed intake - NEL milk 267 
production - NEL maintenance. From this, the energy input from daily dry matter 268 
intake (DMI) was calculated by multiplying the weekly NEL with the observed DMI. 269 
Daily measures of milk yield were combined with the less frequent analyses of fat, 270 
protein and lactose content using the closest composition measure forwards in time 271 
to obtain the NEL used for milk production. EBAL was only calculated if both morning 272 
and evening yield were available for the current day. Afterwards, three days (i.e. +/- 1 273 
12 
 
DIM) moving averages of EBAL were calculated and used for the analyses 274 
(Supplementary Table S1). The average BW within calendar week was used to 275 
smooth large day-to-day variation and measurement errors of scales.  276 
PI-index was calculated as [log10(NEFA)] + [log10(BHB)] − [glucose] (Moyes et 277 
al., 2013), where plasma concentrations of the individual metabolites were 278 
standardised to an overall mean of zero and variance of one (as indicated by square 279 
brackets).  280 
 281 
Statistical analysis 282 
Statistical analyses and calculations were carried out using R 3.4.4 (R Core 283 
Team, 2018) and a 5% level of significance was chosen. Descriptive statistics were 284 
calculated as mean, SD, minimum, maximum, and quartiles. Multilevel random 285 
regression models, with the levels herd/diet and cows were used to estimate the 286 
variance components in the potential milk and blood biomarkers adjusted for DIM 287 
and parity. In the models for EBAL and milk metabolites and milk enzymes, DIM was 288 
included as quadratic term and all two-way interactions were included. Similar 289 
models with DIM as a 2-level factor (DIM14 and DIM35) were used to estimate the 290 
variance components in the potential blood biomarkers and PI-index. 291 
The Intra class Correlation Coefficient (ICC) was calculated as the proportion 292 
of the total variance which could be attributed to a specific level (herd/diet or cow). 293 
For example: 294 
ICCcow = Varcow / (Varherd/diet + Varcow + Residual) 295 
describes the proportion of the variance that can be attributed to cows, that are 296 
adjusted for the covariates. Model control was done by assessing qq-plots and plots 297 
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of residuals vs fitted values and residuals vs DIM for each herd/diet combination and 298 
parity group.  299 
 300 
Results 301 
Production and health data 302 
Summary statistics for daily milk yield for each of the herds (and by diet in the 303 
case of UK and DK) are presented in Table 2. Milk yield over the seven-week period 304 
averaged 33.3 ± 9.3 kg/day, increasing from 25.8 ± 8.1 kg/day in week 1 to 36.1 ± 9.3 305 
kg/day in week 7. Of the 234 cows on the study, 73 had a clinical diagnosis recorded 306 
(Table 3), with mastitis, metritis, retained placenta and endometritis being the 307 
predominant health issues. Eleven of the recorded diagnoses could be associated 308 
directly with metabolic disease.  309 
The production results and cow characteristics were within the expected range 310 
for Holstein dairy cows in early lactation (Table 2). Despite some of the diets being 311 
designed to create metabolic challenges (e.g. Ketogenic ‘High Sugar’ diet in DK), the 312 
health records demonstrated that the cows had a high metabolic health status (Table 313 
3). The limited number of clinical diseased cows would most likely only be a minor 314 
contribution to the overall variation in the biomarkers, however there could be 315 
systematic differences in detection and treatment thresholds in the different herds 316 
that could have resulted in failure to observe some cases. This also indicates that the 317 
vast majority of the observations of EBAL, milk metabolites, milk enzymes and blood 318 
metabolites were within the range of variation that could be expected from different 319 
herds with individual diets and management and other assignable causes of 320 
variation. The observations from this study can be used to estimate variance 321 
components related to herd/diet, cows and within cows related to normal process 322 
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variation. However, the process variation will be overestimated because the 323 
assignable causes (also diseases) have not been removed. 324 
 325 
Energy Balance, milk metabolites and milk enzymes  326 
EBAL was calculated for the three herds (UK, DK and IE) which had the 327 
necessary feed intake and ration composition data available (n=132 cows). While 328 
there were some missing values (weeks 1 and 7 in particular), the average coverage 329 
from six to 47 DIM was 82%.  Average EBAL within each herd/diet combination 330 
ranged from -29.9 MJ/day in the low concentrate diet in UK to 3.1 MJ/day in the high 331 
concentrate diet in UK (with all other diets in between: Supplementary Table S1), and 332 
a standard deviation within diet from 24.9 to 33.2 MJ/day. High concentrate and high 333 
starch diets offered in UK and DK, respectively, increased EBAL. Summary statistics 334 
of EBAL with respect to parity groups are shown in Supplementary Table S2 and 335 
summary statistics in relation to DIM for the milk metabolites and enzymes are shown 336 
in Supplementary Tables S3 and S4.  337 
In Table 4, the variance components and ICCs from the multilevel regression 338 
models of milk metabolites, milk enzymes and the composite EBAL measure are 339 
shown, when DIM and parity are accounted for. The ICC for herd/diet ranged from 340 
12% for Glucose-6-phosphate and LDH to 46% for urea. The ICC for cow ranged 341 
from 17% for urea to 48% for NAGase. The percentage of the total variance that can 342 
be explained by herd/diet or cow effects (sum of ICCherd/diet and ICCcow), ranged from 343 
42% for isocitrate to 63% for urea, with the majority around 50%. The ratio between 344 
herd/diet variance and cow variance ranged from 0.30 for LDH and NAGase to 2.55 345 
for urea. A high ratio indicates that herd/diet is a far more important source for 346 
variation than the individual cow. Supplementary Figures S1-S9 provide additional 347 
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description and model control, herd/diet and parity predictions, together with 348 
residuals vs. fitted values and residuals vs. DIM for overall EBAL and each of the 349 
individual milk biomarkers. The figures show the overall predicted trends in the milk 350 
biomarkers between DIM 1-50 and the average difference between herd/diet and 351 
parity. The residual plots of residuals vs. fitted values demonstrate outliers in many of 352 
the biomarkers and issues related to variance homogeneity between parity groups 353 
and between different herd/diet combinations and in some plots trends and funnel 354 
shapes were observed. The qq-plots (not shown) showed some issues with the 355 
normality assumptions especially for BHB, LDH and NAGase, and that log10-356 
transformation did not entirely solve this.  357 
 358 
Blood metabolites, IGF-1 and Physiological Imbalance-index  359 
Descriptive statistics of the blood metabolites, IGF-1 and PI-index measured at 360 
approximately 14 and 35 DIM are presented in Supplementary Table S5. The 361 
variance components and the ICCs related to herd/diet and cow are given in Table 5. 362 
The ICC for herd/diet ranged from 17% for cholesterol to 47% for urea, when 363 
DIM and parity were accounted for. The ICC for cows ranged from 23% for urea to 364 
54% for cholesterol. The percentage of the total variance that could be explained by 365 
herd/diet or cow effects (sum of ICCherd/diet and ICCcow), ranged from 56% for NEFA 366 
to 75% for IGF-1, with the majority around 60%. The ratio between herd/diet variance 367 
and cow variance ranged from 0.31 for cholesterol to 2.03 for urea. The models were 368 
checked by boxplots of the residuals on the two time points and plots of residual vs. 369 
fitted values and no obvious deviations were found.  370 
Comparing the ICCs from milk vs blood for urea, glucose and BHB showed 371 
that the ICCs were roughly equal, except for the herd/diet ICC for BHB (20% for milk 372 
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vs 46% for blood). Generally, the clustering of the observations (correlation between 373 
observations) within herds and cows are able to explain a larger proportion of the 374 
total variance in blood than in milk.  375 
 376 
Discussion 377 
In this study less than 5% of the cows developed metabolic diseases across a 378 
range of very different feeding, housing and management conditions. The disease 379 
incidence could be underestimated because disease detection followed the normal 380 
management in the herds. However, these were research herds and would generally 381 
be considered as well managed and it is not unlikely that these cows are robust and 382 
are not easily “pushed” towards physiological imbalance by diet challenges. We now 383 
assume that the diseased cows only contribute little to the variation in the biomarkers 384 
because of the fairly low observed disease incidence. We could have chosen to 385 
remove the diagnosed cows from the data/analysis but we prefer this more 386 
transparent approach of not reducing data based on uncertain diagnostic criteria.  387 
 We estimated the variance components related to herd/diet, cow and 388 
within cow/random variation adjusted for parity and DIM at sampling. These two 389 
adjustments reduced the amount of variation at a cow-level (parity adjustment) and 390 
within cows (DIM at sampling). Generally the proportion of the variation that could be 391 
associated with cow or herd/diet were higher for the blood metabolites than milk 392 
metabolites and milk enzymes, which may in part be due to the limitation of having 393 
only two observations per cow in the study period for the blood metabolites. The ICC 394 
for herd/diet for plasma urea and BHB were 0.47 and 0.46, indicating that almost half 395 
of the variation in these observations should be associated with herd/diet factors 396 
common to all cows in the herd. For plasma urea and BHB, the ratio between 397 
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herd/diet variance and cow variance were 1.6 and 2.0, and the total proportion of 398 
variance associated with either herd/diet or cow was 70% and 74% respectively. The 399 
other blood metabolites showed proportions between herd/diet variance and cow 400 
variance around and below 1, which indicates that cow variation was relatively more 401 
important. For urea the results were as expected, because dietary protein intake 402 
influences blood urea (Carroll et al., 1988) and there is substantial variation in blood 403 
urea in relation to feeding (Gustafsson and Palmquist, 1993), which would provide a 404 
distribution of the variation as found here. The descriptive boxplots of log10(BHB) in 405 
blood (Supplementary Figure S10), highlight substantial variation between herd/diet, 406 
but also that the distribution of the observations within herd/diet were almost identical 407 
at 14 and 35 DIM. A commonly applied threshold for BHB in blood is 1.2 mM (0.08 on 408 
log10-scale) for subclinical ketosis in both practice and academia. There are cows 409 
that cross this threshold in DK (High Sugar diet), BE and DE. Comparing these 410 
results with the EBAL estimated from UK, DK and EI (Supplementary Table S1) 411 
suggest that it is not only EBAL that determines blood BHB concentrations, since 412 
there are no high BHB levels in the herd/diet combination with the highest negative 413 
EBAL, and none in the DK standard diet, with the latter very similar in EBAL to the 414 
‘High Sugar’ diet, that were designed to be ketogenic. These results suggest that 415 
fixed thresholds for BHB in blood can be problematic to describe the metabolic status 416 
of a cow. 417 
 For metabolites and enzymes measured in milk, less of the variation 418 
could be attributed to herd/diet or cow. Urea in milk followed the same pattern as 419 
urea in blood, whereas for BHB the ICCherd/diet was reduced from 46% in blood to 420 
20% in milk. For milk BHB the total amount of variation that could be attributed to 421 
herd/diet or cow was 54%. Because there are diurnal fluctuations in blood BHB 422 
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relative to feeding (Quiroz-Rocha et al., 2010) and also within total mixed ration 423 
based systems (Nielsen et al., 2003), it could be hypothesized that milk BHB 424 
provides a more robust indicator of the metabolic challenges in the cow. In addition, 425 
the relatively high ICCherd/diet for BHB in blood might be explained by variation 426 
between blood sampling time points between herds (morning vs. afternoon).  427 
 Glucose in milk is not produced by the mammary epithelia cells but is 428 
transported directly from the blood stream. However, the mammary epithelia also 429 
utilise glycose for multiple metabolic pathways, including conversion to lactose 430 
(Annison, 1983). Larsen and Moyes (2015) also found large variations in the glucose 431 
and glucose-6-phosphate in milk, but also stressed that more work is needed to 432 
identify the mechanisms that can relate these metabolites to disease risk. Residual 433 
analysis of the relations between the same blood and milk metabolites could be a 434 
useful approach to understand these relations in more details including the variation 435 
related to herd/diet. 436 
 The enzymes LDH and NAGase are enzymes that are commonly used 437 
as udder health indicators. In this study we found ICCherd/diet of 12% and 15% for LDH 438 
and NAGase, and the ratio between herd/diet and cow variance was 0.3 for both. 439 
These results are in line with the study of Åkerstedt et al. (2011), who also suggested 440 
that the use of LDH as an indicator of mastitis requires adjustment for the individual 441 
cow (and quarter). The variance that is attributed to the herd/diet was the lowest 442 
found in this study, and is likely related to differences in mastitis incidence between 443 
the different herds. 444 
 The results presented here describe biomarkers in early lactation cows in 445 
a range of different environments, management and feeding strategies. The variance 446 
components can then be considered an estimate of normal variation in the 447 
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biomarkers, when parity and DIM are accounted for. However, as demonstrated by 448 
the supplementary figures S1-S9 accounting for herd/diet, parity and DIM did not 449 
explain all the variation in the data, which indicates that other (unobserved) sources 450 
of variations contribute to the residual variation. The number of outliers, the 451 
differences in residual variance between parity groups and diets and trends in the 452 
residuals suggest that this is not only true random error of the production process. 453 
We have shown that herd and DIM contribute to the total variation in the biomarkers, 454 
but the residual plots indicate that other sources of variation exist as well. A potential 455 
source of variation could be physiological imbalance and these deviations could be 456 
considered predictors of disturbed a production process. If these biomarkers should 457 
be used for monitoring at an individual cow level, these additional sources of 458 
variation should be identified and removed, thereby reducing total variation and 459 
improving the predictability of the biomarker. Other diseases could be potential 460 
assignable causes of variation in the biomarkers. Identification of sources of variation 461 
will be a continuous process involving carefully scrutinizing outliers and deviations in 462 
variation in each of the biomarkers. Based on this study, NAGase and LDH are not 463 
heavily influenced by herd factors so these could be considered useful biomarker for 464 
mastitis on cow level and useful for PLF. The other biomarkers, like BHB, is 465 
influenced by herd factors which suggests that thresholds should be set locally to 466 
describe the metabolic status of the cows and further work is needed to do this. 467 
However in general, the larger the difference in a biomarker between healthy and the 468 
metabolically challenged populations, the greater the amount of variation that can be 469 
accepted within the healthy population. The variance components as depicted here 470 
can be used to provide some guidelines into what should be considered exceptional 471 
variation. Variation associated with the cow and herd/diet level are of importance, 472 
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because these cannot just be accounted for by additional recordings of the individual. 473 
In addition, a common threshold for intervention cannot be applied unless there is a 474 
large difference between the healthy and imbalanced populations. Variation in the 475 
biomarkers between the cows are most likely the most problematic source of 476 
variation, because this necessitates multiple observations for each cow. Between-477 
cow variation is described for acetoacetate and BHB as ‘individual sensitivity for 478 
hyperketonemia’ in the appearance of clinical signs of ketosis (Andersson, 1984). 479 
Herd/diet variations would be less of a challenge, because the PLF tool would only 480 
need to be adjusted for each herd and/or diet.  In addition, the variances in the 481 
biomarkers presented here could be beneficial in simulation studies to estimate 482 
potential impact of PLF with varying prevalences of metabolic disease.  483 
  484 
Conclusions 485 
The ICCs for the milk metabolites and blood metabolites demonstrated that varying 486 
proportions of the variance could be associated with herd/diet and individual cow. 487 
ICC related to the herd-diet combination were generally higher for blood metabolites 488 
than milk metabolites. These results provide valuable information about the variation 489 
in a range of biomarkers, which can be used for subsequent simulations to assess 490 
the potential of the biomarkers in PLF. 491 
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Table 1 Overview of the diets fed to the 234 Holstein dairy cows within the six 633 
experimental herds  634 
Herd Ingredients Diet N cows 
UK 
Three iso-nitrogenous diets comprising mixtures 
of grass silage and concentrate in different ratios 
on a dry matter basis. 
Low C: 30% 20 
Standard C: 50% 20 
High C: 70% 21 
DK 
Three iso-nitrogenous and iso-calorific diets 
comprising grass silage, maize silage, sugar 
beet pulp pellets, and concentrate including high 
level of barley in the “High starch” diet and high 
level of dextrose in the “High sugar” diet. The 
‘High starch’ diet was intended to induce 
acidosis and the ‘High Sugar’ diet was intended 
to induce ketosis. 
High starch: 54% C 11 
High sugar: 54% C 10 
Standard: 49% C 14 
IE 
A standard diet comprising grass silage, maize 
silage, sugar beet pulp pellets, and concentrate. 
In addition, each cow was offered 8 kg of 
concentrate per day in the parlour at milking. 
Standard: 20% C 36 
BE 
A standard diet changing over time to include 
summer grazing. The standard diet comprised 
grass silage, maize silage, and concentrate. 
Moreover, cows were offered 1 kg concentrate 
per 2.5 l milk above 25 l/day with a maximum of 
6 kg C/day at milking. 
Standard: 17% C 31 
DE 
A standard diet comprising grass silage, maize 
silage, and concentrate. 
Standard: 50% C 26 
IT 
A standard diet comprising sorghum silage, 
alfalfa hay, meadow hay, and concentrate. 
Standard: 30% C 45 
C: concentrate 635 
  636 
28 
 
Table 2 Summary statistics for daily milk yield (kg/day) of Holstein dairy cows over 637 
the study period (1 to 50 days-in-milk (DIM)) 638 
Herd Diet Mean (SD) Median (Q1 ; Q3) Min ; Max Ncows Nsamples 
UK 
Low C 28.5 (7.4) 27.9 (22.8 ; 33.4) 14.0 ; 56.1 20 820 
Standard C 32.6 (9.3) 33.1 (25.1 ; 39.6) 7.9 ; 57.0 20 859 
High C 37.2 (10.3) 38.9 (29.2 ; 45.0) 7.7 ; 64.5 21 870 
Pooled 32.8 (9.8) 32.6 (25.4 ; 40.2) 7.7 ; 64.5 61 2549 
DK 
High starch 37.7 (10.7) 36.8 (28.9 ; 44.6) 13.0 ; 63.1 11 465 
High sugar 35.4 (7.1) 36.4 (30.6 ; 40.3) 14.0 ; 51.3 10 452 
Standard 39.7 (9.4) 39.5 (33.6 ; 47.2) 7.5 ; 61.8 14 609 
Pooled 37.8 (9.4) 37.6 (31.5 ; 44.3) 7.5 ; 63.1 35 1526 
IE Standard 33.0 (7.1) 33.3 (29.1 ; 37.9) 10.4 ; 52.4 36 1442 
BE Standard 30.5 (8.6) 30.1 (24.6 ; 35.9) 7.0 ; 62.2 31 1324 
DE Standard 38.6 (8.5) 39.6 (34.9 ; 44.4) 2.7 ; 62.3 25 1139 
IT Standard 29.8 (8.0) 30.3 (24.1 ; 35.8) 3.3 ; 50.8 43 2089 
All Pooled 33.3 (9.3) 33.6 (26.8 ; 39.5) 2.7 ; 64.5 231 10 069 
C: concentrate, Q1: first quartile, Q3: third quartile. 639 
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Table 3 Clinical diagnoses of Holstein dairy cows during the period from calving to 50 641 
Days in Milk (73 cows had a clinical diagnosis, while 161 cows had no clinical 642 
diagnoses recorded) 643 
ICAR Term 1 ICAR code Occurrence 
Anoestria 2.05.02.01.02. 4 
Bronchopneumonia 1.06.07.06. 8 
Digital dermatitis 1.10.07.10. 1 
Displaced abomasum 1.07.12.05. 6 
Endometritis 2.05.01.01. 19 
Interdigital hyperplasia 1.10.06.10. 4 
Lameness 1.09.05. 9 
Mastitis 1.13. 43 
Metabolic diseases and deficiencies 6. 1 
Metritis 2.04.05.02. 20 
Milk fever 6.03.01.01. 4 
Peritonitis 1.07.14.03. 3 
Retained placenta 2.04.03. 20 
Sole ulcer 1.10.07.03. 1 
Total (n=73 cows)  143 
1 ICAR terms sorted alphabetically. 644 




Table 4 Variance components and Intra Class Correlations (ICC) on Energy Balance 647 
(EBAL) and milk metabolites and enzymes from early lactation Holstein dairy cows. 648 
In the model variation that could be attributed to parity and lactation stage is 649 





Residual ICCherd/diet ICCcow Herd/diet 
variance : Cow 
variance 
EBAL1 125 289 389 0.15 0.36 0.43 
Uric Acid 611 687 1746 0.20 0.23 0.89 
Urea 0.84 0.33 0.66 0.46 0.17 2.55 
Isocitrate 0.0003 0.0005 0.0011 0.18 0.24 0.60 
log10(BHB2) 0.0096 0.0163 0.0221 0.20 0.34 0.59 
Glucose 0.0024 0.0026 0.0033 0.29 0.31 0.92 
Glucose-6-
phospate 
0.0005 0.0015 0.0020 0.12 0.37 0.33 
log10(LDH3) 0.0078 0.0263 0.0325 0.12 0.39 0.30 
log10(NAGase4) 0.0066 0.0220 0.0169 0.15 0.48 0.30 
1: Energy Balance was calculated for three herds (UK, DK and IE) and 7 diets.  651 
2: β-hydroxybutyrate. 652 
3: N-acetyl-β-D-glucosaminidase. 653 
4: lactate dehydrogenase. 654 
 655 
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Table 5 Variance components and Intra Class Correlations (ICC) on Physiological 657 
Imbalance-index (PI-Index), IGF-1 and blood metabolites from early lactation 658 
Holstein dairy cows. In the model variation that could be attributed to parity and 659 





Residual ICCherd/diet ICCcow Herd/diet 
variance : Cow 
variance 
PI-index 1.59 1.65 1.44 0.34 0.35 0.96 
IGF-1 0.032 0.030 0.021 0.39 0.36 1.07 
Urea 0.65 0.32 0.42 0.47 0.23 2.03 
log10(BHB1) 0.026 0.016 0.014 0.46 0.28 1.63 
log10(NEFA2) 0.019 0.032 0.042 0.21 0.35 0.59 
Glucose 0.064 0.068 0.086 0.29 0.31 0.94 
Fructosamine 94.4 101.4 134.0 0.29 0.31 0.93 
Cholesterol 0.13 0.42 0.23 0.17 0.54 0.31 
1: β-hydroxybutyrate. 661 
2: non-esterified fatty acid. 662 
 663 
